Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Epacadostat by Incyte for Dedifferentiated Liposarcoma: Likelihood of Approval
Epacadostat is under clinical development by Incyte and currently in Phase II for Dedifferentiated Liposarcoma. According to GlobalData, Phase II...